D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 113 Citations 49,353 1,046 World Ranking 2063 National Ranking 1206

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

His primary areas of study are Pathology, Nanotechnology, Carcinoma, Photothermal therapy and Cancer. His Pathology research includes elements of Urinary bladder, Prostate and Prostate cancer. His Prostate cancer research includes themes of Cancer research and Oncology.

In his work, Photosensitizer and Photodynamic therapy is strongly intertwined with In vivo, which is a subfield of Nanotechnology. His Carcinoma course of study focuses on Fluorescence in situ hybridization and Cytogenetics. His research investigates the link between Photothermal therapy and topics such as Polyethylene glycol that cross with problems in Nanomedicine.

His most cited work include:

  • The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma (2002 citations)
  • Functional Nanomaterials for Phototherapies of Cancer (1303 citations)
  • PEGylated WS2 Nanosheets as a Multifunctional Theranostic Agent for in vivo Dual-Modal CT/Photoacoustic Imaging Guided Photothermal Therapy (720 citations)

What are the main themes of his work throughout his whole career to date?

Liang Cheng spends much of his time researching Pathology, Internal medicine, Oncology, Prostate cancer and Cancer. Liang Cheng interconnects Fluorescence in situ hybridization and Urinary bladder in the investigation of issues within Pathology. His Internal medicine research focuses on Bladder cancer in particular.

His research links Immunotherapy with Oncology. His work deals with themes such as Cancer research and Prostate, which intersect with Prostate cancer. His study on Prostate is mostly dedicated to connecting different topics, such as Adenocarcinoma.

He most often published in these fields:

  • Pathology (31.73%)
  • Internal medicine (17.04%)
  • Oncology (14.53%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (17.04%)
  • Cancer research (11.92%)
  • Oncology (14.53%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Cancer research, Oncology, Pathology and Prostate cancer. His study in Renal cell carcinoma, Atezolizumab, PD-L1 and Liquid biopsy is done as part of Internal medicine. Specifically, his work in Cancer research is concerned with the study of Tumor microenvironment.

The concepts of his Oncology study are interwoven with issues in Bladder cancer, Cancer, Pembrolizumab, Immunotherapy and Clinical trial. His Pathology study often links to related topics such as Urinary bladder. His Prostate cancer study combines topics from a wide range of disciplines, such as Prostate and Disease.

Between 2018 and 2021, his most popular works were:

  • Urologic surgical pathology (305 citations)
  • Amplification of Tumor Oxidative Stresses with Liposomal Fenton Catalyst and Glutathione Inhibitor for Enhanced Cancer Chemotherapy and Radiotherapy (101 citations)
  • Ultrasmall Oxygen-Deficient Bimetallic Oxide MnWOX Nanoparticles for Depletion of Endogenous GSH and Enhanced Sonodynamic Cancer Therapy. (99 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

His primary areas of investigation include Cancer research, Internal medicine, Oncology, Pathology and Cancer. His research investigates the connection between Cancer research and topics such as Cancer therapy that intersect with issues in Drug delivery and Nanomaterials. The Oncology study combines topics in areas such as Bladder cancer, Pembrolizumab, Atezolizumab, Immunotherapy and Clinical trial.

Liang Cheng studied Bladder cancer and Carcinoma that intersect with Metastasis, Predictive value of tests and Survival analysis. His Pathology research is multidisciplinary, relying on both Renal neoplasm and Urinary bladder. He is involved in the study of Cancer that focuses on Prostate cancer in particular.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma

Geert J.L.H. van Leenders;Theodorus H. van der Kwast;David J. Grignon;Andrew J. Evans.
The American Journal of Surgical Pathology (2005)

2820 Citations

Functional Nanomaterials for Phototherapies of Cancer

Liang Cheng;Chao Wang;Liangzhu Feng;Kai Yang.
Chemical Reviews (2014)

1404 Citations

Bladder cancer: Epidemiology, staging and grading, and diagnosis

Ziya Kirkali;Theresa Chan;Murugesan Manoharan;Ferran Algaba.
Urology (2005)

1025 Citations

The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

John R. Srigley;Brett Delahunt;John N. Eble;Lars Egevad.
The American Journal of Surgical Pathology (2013)

983 Citations

PEGylated WS2 Nanosheets as a Multifunctional Theranostic Agent for in vivo Dual-Modal CT/Photoacoustic Imaging Guided Photothermal Therapy

Liang Cheng;Jingjing Liu;Xing Gu;Hua Gong.
Advanced Materials (2014)

799 Citations

Drug Delivery with PEGylated MoS2 Nano‐sheets for Combined Photothermal and Chemotherapy of Cancer

Teng Liu;Chao Wang;Xing Gu;Hua Gong.
Advanced Materials (2014)

784 Citations

Multimodal Imaging Guided Photothermal Therapy using Functionalized Graphene Nanosheets Anchored with Magnetic Nanoparticles

Kai Yang;Lilei Hu;Xingxing Ma;Shuoqi Ye.
Advanced Materials (2012)

766 Citations

Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles.

Chao Wang;Huiquan Tao;Liang Cheng;Zhuang Liu.
Biomaterials (2011)

699 Citations

Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy.

Liang Cheng;Kai Yang;Yonggang Li;Jianhua Chen.
Angewandte Chemie (2011)

699 Citations

In vitro and in vivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles.

Kai Yang;Huan Xu;Liang Cheng;Chunyang Sun.
Advanced Materials (2012)

595 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Liang Cheng

Jonathan I. Epstein

Jonathan I. Epstein

Johns Hopkins University

Publications: 233

Zhuang Liu

Zhuang Liu

Soochow University

Publications: 169

Rodolfo Montironi

Rodolfo Montironi

Marche Polytechnic University

Publications: 136

Wei Huang

Wei Huang

Nanjing Tech University

Publications: 135

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 132

Jun Lin

Jun Lin

Chinese Academy of Sciences

Publications: 131

Lars Egevad

Lars Egevad

Karolinska Institute

Publications: 112

Yu Chen

Yu Chen

Shanghai University

Publications: 107

Xiaoyuan Chen

Xiaoyuan Chen

National University of Singapore

Publications: 100

Michal Michal

Michal Michal

Charles University

Publications: 92

Antonio Lopez-Beltran

Antonio Lopez-Beltran

University of Córdoba

Publications: 86

Cristina Magi-Galluzzi

Cristina Magi-Galluzzi

University of Alabama at Birmingham

Publications: 83

George J. Netto

George J. Netto

University of Alabama at Birmingham

Publications: 83

Victor E. Reuter

Victor E. Reuter

Memorial Sloan Kettering Cancer Center

Publications: 83

Mahul B. Amin

Mahul B. Amin

University of Tennessee at Knoxville

Publications: 81

Piaoping Yang

Piaoping Yang

Harbin Engineering University

Publications: 81

Something went wrong. Please try again later.